We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Submit a Media Inquiry

Note: All fields are required. Be sure to fill out all fields before hitting submit. Not doing so could result in loss of entered information.

Media Inquiries

Or Call us at (650) 467-6800